Office of Generic Drugs (OGD/FDA) Awards $1M FDA Contract to C...
PROVIDENCE, Rhode Island, Oct. 2, 2018 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announced today that they have been awarded a two-year $1 million contract from the Food and Drug Administration (FDA) in response to a Broad Agency Announcement (BAA), FDA BAA-17-00123. Logo -...
Read more https://view-release/?pr-id=75529